Juvabis AG is a clinical stage biotech company developing the next generation of aminoglycoside antibiotics. Its first-in-class human therapeutic portfolio demonstrates preclinical safety and efficacy in critical systemic infections by highly drug-resistant Gram-negative pathogens and mycobacteria.

Location
Additional address info
  • c/o Vischer AG
Canton
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2015
  • Number of employees in Switzerland
    1-9
Key business

You may also be interested in